Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20150822023705N12Phase 2Completed
Phase 2, randomised trial in methamphetamine use disorder (MUD) comparing Trimipramine with Placebo (2 arms). Primary endpoints: Temptation to use methamphetamine and Rate of relapse to methamphetamine use. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20150822023705N12.